Primary outcomes
depression, anxiety
In this study, participants are expected to show improvement in anxiety (BAI), and depression (BDI II) at post-treatment (T1) compared to pre-treatment (T0), and this result is expected to remain stable for 3 months (T2). In Wait-List Control, it is expected that there would not be a significant improvement in these variables at T1 compared to T0.The clinical cut-off point for these scales in the Argentine population is 10 points. A cut-off score ≥ 10 in the BDI and BAI indicates clinical anxiety or depression (mild, moderate, or severe). A score ≤ 10 indicates that symptoms of anxiety or depression are not clinically relevant.